{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:17:16Z","timestamp":1793593036450,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015866","name":"Government of the Basque Country Department of Education Linguistic Policy and Culture","doi-asserted-by":"publisher","award":["IT913\\u201316"],"award-info":[{"award-number":["IT913\\u201316"]}],"id":[{"id":"10.13039\/100015866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003451","name":"Euskal Herriko Unibertsitatea","doi-asserted-by":"publisher","award":["GIU21\/017"],"award-info":[{"award-number":["GIU21\/017"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003451","name":"Euskal Herriko Unibertsitatea","doi-asserted-by":"publisher","award":["PIF19\/316"],"award-info":[{"award-number":["PIF19\/316"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.127102","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T08:34:16Z","timestamp":1744101256000},"page":"127102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A synthetic peptide vaccine induces protective immune responses against Candida albicans infection in immunocompromised mice"],"prefix":"10.1016","volume":"53","author":[{"given":"Ander","family":"Diez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Arrieta-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Carrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Breg\u00f3n-Villahoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Dolores","family":"Moragues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Fernandez-de-Larrinoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2025.127102_bb0005","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02462-22","article-title":"Commensal fungus Candida albicans maintains a long-term mutualistic relationship with the host to modulate gut microbiota and metabolism","volume":"10","author":"Peroumal","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127102_bb0010","article-title":"The impact of the fungus-host-microbiota interplay upon Candida albicans infections: current knowledge and new perspectives","volume":"45","author":"d\u2019Enfert","year":"2021","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2025.127102_bb0015","series-title":"Candida and candidosis","author":"Odds","year":"1988"},{"key":"10.1016\/j.vaccine.2025.127102_bb0020","series-title":"Candida and candidiasis","author":"Calderone","year":"2012"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127102_bb0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00091-13","article-title":"Molecular and nonmolecular diagnostic methods for invasive fungal infections","volume":"27","author":"Arvanitis","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127102_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.24171\/j.phrp.2021.0293","article-title":"Worldwide prevalence of fungal coinfections among COVID-19 patients: a comprehensive systematic review and meta-analysis","volume":"13","author":"Soltani","year":"2022","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.vaccine.2025.127102_bb0035","series-title":"Superficial candidosis: Fungal infection","author":"Richardson","year":"2003"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127102_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1130-1406(05)70014-0","article-title":"Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV\/AIDS patients and healthy persons","volume":"22","author":"S\u00e1nchez-Vargas","year":"2005","journal-title":"Rev Iberoam Micol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127102_bb0045","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1128\/JCM.43.8.4159-4162.2005","article-title":"Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico","volume":"43","author":"S\u00e1nchez-Vargas","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127102_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12879-019-4736-2","article-title":"Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon","volume":"20","author":"Ghaddar","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127102_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jof7020079","article-title":"Candida albicans-the virulence factors and clinical manifestations of infection","volume":"7","author":"Talapko","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127102_bb0060","first-page":"21","article-title":"Identification of superficial Candida albicans germ tube antigens in a rabbit model of disseminated candidiasis","volume":"17","author":"S\u00e1ez-Ros\u00f3n","year":"2014","journal-title":"A proteomic approach Int Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127102_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115509","article-title":"Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients","volume":"101","author":"D\u00edez","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.127102_bb0070","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1080\/13693780802552614","article-title":"Vaccine progress","volume":"47","author":"Ito","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.vaccine.2025.127102_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2023.2279570","article-title":"Vaccine development for pathogenic fungi: current status and future directions","author":"Chechi","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127102_bb0080","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1469-0691.2009.02794.x","article-title":"Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients","volume":"15","author":"Zaragoza","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127102_bb0085","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1128\/CVI.00183-09","article-title":"Candida Albicans germ tube antibody detection in critically ill patients study group. Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality","volume":"16","author":"Zaragoza","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127102_bb0090","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/prca.200601036","article-title":"Reliability of antibodies to Candida methionine synthase for diagnosis, prognosis and risk stratification in systemic candidiasis: a generic strategy for the prototype development phase of proteomic markers","volume":"1","author":"Pitarch","year":"2007","journal-title":"Proteomics Clin Appl"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127102_bb0095","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind","volume":"66","author":"Edwards","year":"2018","journal-title":"Placebo-Controlled Trial Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127102_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vaccine.2015.11.035","article-title":"Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis","volume":"34","author":"Xin","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127102_bb0105","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0966-842X(02)02460-5","article-title":"Fungi, dendritic cells and receptors: a host perspective of fungal virulence","volume":"10","author":"Romani","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2025.127102_bb0110","article-title":"In vitro effects of Candida albicans and aspergillus fumigatus on dendritic cells and the role of beta glucan in this effect. Adv","author":"Fidan","year":"2014","journal-title":"Clin Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127102_bb0115","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jprot.2010.02.008","article-title":"Identification of Candida albicans exposed surface proteins in vivo by a rapid proteomic approach","volume":"73","author":"Hern\u00e1ez","year":"2010","journal-title":"J Proteome"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127102_bb0120","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/pmic.201100588","article-title":"Cell surface shaving of Candida albicans biofilms, hyphae, and yeast form cells","volume":"12","author":"Vial\u00e1s","year":"2012","journal-title":"Proteomics"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127102_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.05.038","article-title":"A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis","volume":"42","author":"Diez","year":"2024","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127102_bb0130","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.191.10.1661","article-title":"Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo","volume":"191","author":"d\u2019Ostiani","year":"2000","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127102_bb0135","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.168.6.2904","article-title":"Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation","volume":"168","author":"Bacci","year":"2002","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127102_bb0140","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.169.11.6298","article-title":"B7\/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans","volume":"169","author":"Montagnoli","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127102_bb0145","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4049\/jimmunol.168.3.1362","article-title":"Dendritic cells transport conidia and hyphae of aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus","volume":"168","author":"Bozza","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.127102_bb0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4939-7104-6_12","article-title":"Th1-inducing agents in prophylaxis and therapy for Paracoccidioidomycosis","volume":"1625","author":"da Silva","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127102_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1469-0691.2011.03676.x","article-title":"Adjunctive immunotherapy with recombinant cytokines for the treatment of disseminated candidiasis","volume":"18","author":"van de Veerdonk","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127102_bb0160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/vaccines9101159","article-title":"The role of B-cells and antibodies against Candida vaccine antigens in invasive candidiasis","volume":"9","author":"Shukla","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127102_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4939-7104-6_4","article-title":"Rational Design of T Lymphocyte Epitope-Based Vaccines against Coccidioides Infection","volume":"1625","author":"Hurtgen","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127102_bb0170","doi-asserted-by":"crossref","first-page":"1002406","DOI":"10.3389\/fcimb.2022.1002406","article-title":"Vaccines against candidiasis: status, challenges and emerging opportunity","volume":"18","author":"Sahu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127102_bb0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-6-55","article-title":"Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases","volume":"17","author":"Zuluaga","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127102_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127102_bb0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1369-5274(02)00337-5","article-title":"Induced humoral immunity and vaccination against major human fungal pathogens","volume":"5","author":"Casadevall","year":"2002","journal-title":"Curr Opin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127102_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/13693780701883508","article-title":"Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis","volume":"46","author":"Raska","year":"2008","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127102_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00436540","article-title":"Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice","volume":"91","author":"Maiti","year":"1985","journal-title":"Mycopathologia"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127102_bb0200","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.154.10.5273","article-title":"Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes","volume":"154","author":"Beno","year":"1995","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127102_bb0205","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3892\/br.2014.365","article-title":"Early expression of local cytokines during systemic Candida albicans infection in a murine intravenous challenge model","volume":"2","author":"Chin","year":"2014","journal-title":"Biomed Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127102_bb0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chom.2012.04.008","article-title":"Th17 cells in immunity to Candida albicans","volume":"11","author":"Hern\u00e1ndez-Santos","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127102_bb0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13054-020-02977-5","article-title":"Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis","volume":"24","author":"Li","year":"2020","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127102_bb0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar3893","article-title":"Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy","volume":"14","author":"Huppler","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127102_bb0225","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/21505594.2015.1004977","article-title":"Adaptive immune responses to Candida albicans infection","volume":"6","author":"Richardson","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2025.127102_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110550","article-title":"Immune defence to invasive fungal infections: a comprehensive review","volume":"130","author":"Pathakumari","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127102_bb0235","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/515645","article-title":"Candidiasis in interferon-gamma knockout (IFN-gamma\u2212\/\u2212) mice","volume":"178","author":"Balish","year":"1998","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127102_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2015.07.025","article-title":"Beyond Candida albicans: mechanisms of immunity to non-albicans Candida species","volume":"76","author":"Whibley","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127102_bb0245","first-page":"117","article-title":"Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein","volume":"27","author":"Londono","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127102_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection","volume":"15","author":"Singh","year":"2019","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:21:29Z","timestamp":1777537289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25003998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":50,"alternative-id":["S0264410X25003998"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127102","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A synthetic peptide vaccine induces protective immune responses against Candida albicans infection in immunocompromised mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127102"}}